Together, our and previous results motivate future mechanistic studies that unravel the expression and functional role of especially ADM and ST2 in SCLC and other cancers to understand how these peptides may locally influence the tumor microenvironment and represent tractable targets for anti-tumoral therapies. This evidence concerns the gene ADM and neoplasm.